Navigation Links
Positive results from Phase 1/2 stem cell trial reported
Date:11/6/2012

San Carlos, CA; November 6, 2012 BioCardia, Inc., focused on regenerative biologic therapies for cardiovascular disease, today announced positive results from a Phase 1/2 heart failure trial using the Company's Helical Infusion System, comprising the Helical Infusion System Catheter and Morph Vascular Access Catheter, to deliver allogeneic, or "off-the-shelf," and autologous, or from the treated patient, mesenchymal (adult) stem cells (MSCs) via transendocardial injection. According to the results, both the allogeneic and autologous MSCs were safe and well-tolerated at all doses and demonstrated similarly positive effects on cardiac structure and function, patient functional capacity and quality of life. Results from the POSEIDON (Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis) study were reported in a late breaker presentation titled, "Randomized Comparison of Allogeneic vs Autologous Mesenchymal Stem Cells in Patients with Ischemic Cardiomyopathy," at the American Heart Association's 2012 Scientific Sessions and have been published in an article in the November 6 edition of the Journal of the American Medical Association. The POSEIDON study was cosponsored by the NIH Specialized Center for Cell Therapy, the University of Miami, and BioCardia.

Joshua Hare, M.D., Director of the Interdisciplinary Stem Cell Institute (ISCI) at the University of Miami Miller School of Medicine, and the POSEIDON study lead principal investigator, stated, "The combination of Allogenic MSCs with the BioCardia Helix catheter has enormous potential as a combination product for treating heart failure. The strong safety results and ease of the catheter delivery procedure in skilled hands, coupled with the potential for the use of allogeneic stem cells, suggest that this procedure may one day be as easy to perform as coronary angioplasty."

Peter Altman, Ph.D., President and CEO of BioCardia, commented, "The Helical Infusion System is inte
'/>"/>

Contact: Miranda Peto
mpeto@biocardia.com
650-226-0129
BioCardia, Inc.
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. PARP inhibitors may have clinical utility in HER2-positive breast cancers
2. Religions play positive role in African AIDS crisis
3. Physicians empathy directly associated with positive clinical outcomes, confirms large study
4. Crizotinib reduces tumor size in patients with ALK positive lung cancer
5. Weight-loss surgery results in positive changes in social life, medical conditions
6. Why do older adults display more positive emotion? It might have to do with what they’re looking at
7. Study examines characteristics, risk factors among HIV-positive persons born outside the US
8. HPV testing in HIV-positive women may help reduce frequent cervical cancer screening
9. Higher levels of public reimbursement positively influence national birth rates and reduce unmet needs in subfertile populations
10. Surgeons Seek Repeal of Transplant Ban Between HIV-Positive People
11. NIH study finds HIV-positive young men at risk of low bone mass
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... The National Association of Professional Women ... 2015-2016 inductee into its VIP Woman of the Year ... leadership in business. NAPW is the nation's leading networking ... members and over 200 operating Local Chapters. , “I'm ... NAPW President Star Jones. “Her perseverance, work ethic and ...
(Date:5/4/2015)... Friday afternoon at A Forever Recovery, a result-driven substance ... staff gather in the common room to celebrate the ... gain encouragement and inspiration in their continuing effort to ... patients who have completed their recovery programs come to ... a bit about their journey with the audience. Some ...
(Date:5/4/2015)... 2015 HHT is a rare but ... While it can have seemingly mild symptoms like frequent ... Hereditary Hemorrhagic Telangiectasia (HHT) is a hereditary disorder ... normal capillary connections between an artery and a vein. ... nosebleeds, but may also be present in the lungs, ...
(Date:5/4/2015)... York, New York (PRWEB) May 04, 2015 ... much as $2.4 billion to settle thousands of Actos ... 2 diabetes medication increases the risk that a patient ... issued on April 28th, if 95% of those eligible ... will resolve nearly 9,000 bladder cancer cases currently pending ...
(Date:5/4/2015)... “ LiveSchool ” was featured on NewsWatch as part ... the latest and coolest applications on the market for ... AppWatch and technology expert, conducted the app review and ... reward students with good behavior. , Positive re-enforcement is ... And the good people at LiveSchool have taken ...
Breaking Medicine News(10 mins):Health News:NAPW Inducts Patti Hommes, Director of Advancement Services, Springside Chestnut Hill Academy, a 2015-2016 Professional Woman of the Year Circle 2Health News:A Forever Recovery Celebrates New Victories in Overcoming Addiction With Weekly Graduation 2Health News:Frequent Nosebleeds Can Be a Sign of a Rare Undiagnosed Disease - Cure HHT 2Health News:Frequent Nosebleeds Can Be a Sign of a Rare Undiagnosed Disease - Cure HHT 3Health News:Actos Lawsuit Settlement: Takeda Pharmaceutical Co. to Pay As Much As $2.4 Billion to Resolve Claims Alleging Actos Causes Bladder Cancer 2Health News:Actos Lawsuit Settlement: Takeda Pharmaceutical Co. to Pay As Much As $2.4 Billion to Resolve Claims Alleging Actos Causes Bladder Cancer 3Health News:An Application for Teachers to Reward Students with Good Behavior Was Featured on NewsWatch Television 2
... ... ... ... ...
... ... ... , ... ...
... ... ... ... ...
... shown to be effective in breast cancer packs an effective ... a specific genetic mutation, a study at UCLA,s Jonsson Comprehensive ... when given together proved to significantly inhibit tumor growth in ... mutation that results in an aggressive form of the disease, ...
... scientists studying acute forms of Leukaemia have identified a new ... the growth of diseased cells. The research, reported in ... to genes, which if targeted could prevent diseased cells from ... the University of Vienna, carried out their research on acute ...
... bone mineral density, strength and postural balance due to ... group of women but also for elderly men, says ... and continues "It is well known that the risk ... result of weaker bones, poorer balance and attenuated ability ...
Cached Medicine News:Health News:AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 2Health News:AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 3Health News:AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 4Health News:AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 5Health News:AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 6Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 2Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 3Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 4Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 5Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 6Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 7Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 8Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 9Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 10Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 11Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 12Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 13Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 14Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 15Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 16Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 17Health News:Marketech Celebrates 25 Years of Service 2Health News:Marketech Celebrates 25 Years of Service 3Health News:Marketech Celebrates 25 Years of Service 4Health News:Marketech Celebrates 25 Years of Service 5Health News:Herceptin and Tykerb effective against a subset of gastric cancers 2Health News:Herceptin and Tykerb effective against a subset of gastric cancers 3Health News:Targeting leukemia cell's gene 'addiction' presents new strategy for treatment 2Health News:Soccer reduces risk of falls and bone fractures 2Health News:Soccer reduces risk of falls and bone fractures 3
(Date:5/4/2015)... May 4, 2015 Southfield Capital, ... firm, announced today that it completed a ... Communications. BioPharm specializes in the development and multi-channel ... pharmaceutical and biotechnology industries. Through ... shareholders half of their invested capital and ...
(Date:5/4/2015)... -- PharmaEngine, Inc. (TWO:4162) today announced that its ... ) with its sublicensing partner, Baxter International Inc. ... has submitted a marketing authorization application (MAA) to ... liposome injection), also known as "nal-IRI," in patients ... been previously treated with gemcitabine-based therapy. ...
(Date:5/4/2015)... DENVER , May 4, 2015  By ... now possible to distinguish between two very different ... to Theodore Henderson , MD, PhD., a ... diagnosing complex cases, this study can ... differences, and therefore treatment options, for Post-Traumatic Stress ...
Breaking Medicine Technology:Southfield Capital and BioPharm Communications Announce Dividend Recapitalization 2PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 2PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 3New Medical Research Shows Brain Imaging Can Now Help Doctors Differentiate Between PTSD and Traumatic Brain Injuries 2New Medical Research Shows Brain Imaging Can Now Help Doctors Differentiate Between PTSD and Traumatic Brain Injuries 3
... Holdings, Inc., (NYSE: HRC ) invites you ... Suisse,s 2011 Healthcare Conference in Phoenix on November 9, ... invited to listen to the live discussion via the ... directly at http://cc.talkpoint.com/cred001/110911a_ah/?entity=1_CIKQF3F .  A recorded replay of ...
... Epilepsy Therapy Project (ETP), a non-profit organization whose mission ... epilepsy and seizures and the parent organization of epilepsy.com, ... inviting entries that represent the most innovative ideas in ... Shark Tank competition will receive national recognition and a ...
Cached Medicine Technology:Epilepsy Therapy Project Announces "Shark Tank" Competition to Identify the Most Innovative, New Products for People with Epilepsy 2Epilepsy Therapy Project Announces "Shark Tank" Competition to Identify the Most Innovative, New Products for People with Epilepsy 3
... Optima L-XP ultracentrifuge is designed ... the discovery process if research involves ... a sophisticated on-board computer, enhanced firmware, ... easy-to-use touch screen, Optima L-XP delivers ...
... With the ability to provide a simple, ... in lipemic samples), the Airfuge CLS delivers ... can be cleaned in 10 minutes, eliminating ... tabletop centrifuge: Reaches top speed in as ...
... integrated chemistry system brings versatility in ... smaller laboratory. A model of innovation ... chemistry system features state-of-the-art Dimension testing ... environment, in a flexible. affordable, easy-to-use ...
The Dimension RxL Max is an integrated chemistry system and is the most powerful and technologically advanced Dimension analyze with new standard for excellence in clinical diagnostics. Simply put, t...
Medicine Products: